(Q34543496)

2 August 2017

1 reference

title

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. (English)

1 reference

2 August 2017

1 reference

1 reference

1

Swanson JM

1 reference

2 August 2017

Volkow ND

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Behavioural Brain Research

2 August 2017

published in

1 reference

2 August 2017

volume

130

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

73-78

1 reference

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Gas chromatographic/mass spectrometric analysis of methylphenidate (ritalin) in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Clinical studies of methylphenidate serum levels in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Clinical correlates of methylphenidate blood levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Effects of methylphenidate on learning a 'beginning reading vocabulary' by normal adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

A reproducible gas chromatographic mass spectrometric assay for low levels of methylphenidate and ritalinic acid in blood and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

More frequent diagnosis of attention deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Autoradiographic localization of [3H]methylphenidate binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Serotonin and the therapeutic effects of ritalin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

On the treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Anti-hyperactivity medication: methylphenidate and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900433-8

7 January 2021

10.1016/S0166-4328(01)00433-8

Identifiers

DOI

1 reference

2 August 2017

1 reference